 |
U.S. healthcare M&A deal value soared to nearly $50 billion in Q2 2013
- Merger and acquisition activity fell to 229 deals from 249 in the first quarter, but higher values on individual deals drove total dollar volume to near record levels at $49.9 billion.
- Several major mergers drove the higher deal dollar value, including Thermo Fisher Scientific’s takeover of Life Technologies Corp. for $13.6 billion and Valeant Pharmaceuticals’ purchase of Bausch & Lomb for $8.7 billion.
- Hospital mergers seized center stage with two of the top five deals during the quarter led by Tenet Healthcare Corp.’s takeover of Vanguard Health Systems for $4.3 billion.
- Providers led the pack in making deals in the second quarter, with hospitals and other provider groups announcing 106 transactions, nearly double its previous quarter’s total.
| Target |
Location |
Seller (if applicable) |
Bidder |
Industry |
Sub-sector |
Purchase price |
Deal announced |
| Onyx Pharmaceuticals |
California |
-- |
Amgen |
Pharma |
Drugs and biologics |
$10,400 |
8/25/2013 |
| Elan Corp. |
Ireland |
-- |
Perrigo Company |
Pharma |
Drugs and biologics |
$8,600 |
7/29/2013 |
| Health Management Associates |
Florida |
-- |
Community Health Systems |
Providers |
Hospitals, acute care |
$3,900 |
7/30/2013 |
| Transitions Optical joint venture |
Florida |
PPG Industries |
Essilor International |
Vendors |
Medical devices |
$1,730 |
7/29/2013 |
| Panasonic Healthcare Co. |
Japan |
Panasonic Corp. |
Kohlberg Kravis & Roberts |
Vendors |
Medical equipment |
$1,670 |
9/27/2013 |
Buy all the 3rd Qtr 2013 M&A data »
| Target |
Location |
Seller (if applicable) |
Bidder |
Industry |
Sub-sector |
Purchase price |
Deal announced |
| Panasonic Healthcare Co. |
Japan |
Panasonic Corp. |
Kohlberg Kravis & Roberts |
Vendors |
Medical equipment |
$1,670 |
9/27/2013 |
| Mako Surgical |
Florida |
-- |
Stryker |
Vendors |
Medical devices |
$1,410 |
9/25/2013 |
| Astex Pharmaceuticals |
California |
-- |
Otsuka Pharmaceutical |
Pharma |
Drugs and biologics |
$866 |
9/5/2013 |
| Greenway Medical Technologies |
Georgia |
-- |
Vista Equity Partners |
Vendors |
Healthcare information |
$644 |
9/23/2013 |
| Harden Healthcare Holdings |
Texas |
-- |
Gentiva Health Services |
Providers |
Post-acute-care |
$408.8 |
9/19/2013 |
Buy all the September 2013 M&A data »
| Target |
Location |
Seller (if applicable) |
Bidder |
Industry |
Sub-sector |
Purchase price |
Deal announced |
| Life Technologies |
Carlsbad, Calif. |
- |
Thermo Fisher Scientific |
Medical devices |
Diagnostics |
$13,600 |
4/15/2013 |
| Bausch & Lomb |
Rochester, N.Y. |
-- |
Valeant Pharmaceuticals |
Pharmaceuticals |
Drugs and biologics |
$8,700 |
5/27/2013 |
| Warner Chilcott |
Rockaway, N.J. |
- |
Actavis |
Pharmaceuticals |
Drugs and biologics |
$8,500 |
5/20/2013 |
| Vanguard Health Systems |
Nashville |
- |
Tenet Healthcare Corp. |
Providers |
Hospitals, acute-care |
$4,300 |
6/24/2013 |
| Revera |
Ontario, Canada |
-- |
Health Care REIT |
Providers |
Senior housing |
$1,350 |
5/8/2013 |
Buy all the 2nd Qtr 2013 M&A data »
| Target |
Location |
Seller (if applicable) |
Bidder |
Industry |
Purchase price |
Deal announced |
| AssuraMed Holding |
Twinsburg, Ohio |
- |
Cardinal Health |
Pharmaceutical, Life Sciences & Biotechnology |
$1,940 |
2/14/2013 |
| Agila Specialties |
India |
-- |
Mylan |
Pharmaceutical, Life Sciences & Biotechnology |
$1,600 |
2/27/2013 |
| AmerisourceBergen |
Chesterbrook, Pa. |
- |
Walgreens and Alliance Boots |
Pharmaceutical, Life Sciences & Biotechnology |
$800 |
3/19/2013 |
| MAP Pharmaceuticals |
Mountain View, Calif. |
- |
Allergan |
Pharmaceutical, Life Sciences & Biotechnology |
$768 |
1/22/2013 |
| Trauson Holdings Co. |
China |
-- |
Stryker Corp. |
Vendor |
$677.6 |
1/17/2013 |
Buy all the 1st Qtr 2013 M&A data »
This report series covers trends and analyzes recent activity in the U.S. healthcare mergers and acquisitions market. Activity among the provider, payer, vendor and pharmaceutical/biotechnology sectors of the healthcare industry is comprehensively covered.
Q: What is Healthcare M&A Watch?
A: Healthcare M&A Watch is a digital report produced on a quarterly basis that covers trending and analysis of U.S. mergers and acquisitions among providers, payers, vendors and pharma/life sciences sectors of the healthcare industry. You can purchase the quarterly report individually for $199.
Q: I have a paid ModernHealthcare.com subscription. Can I get the Healthcare M&A Watch for free?
A: Yes, if you are a Premium Web subscriber. Premium Web subscribers have access to all the By The Numbers PDFs and research from Modern Healthcare Insights that are uploaded to our Healthcare Business Data Center.
|
|
|
|
|
